2.60
price up icon4.42%   0.11
pre-market  プレマーケット:  2.60  
loading
前日終値:
$2.49
開ける:
$2.45
24時間の取引高:
546.82K
Relative Volume:
0.42
時価総額:
$24.15M
収益:
-
当期純損益:
$-45.57M
株価収益率:
-0.4127
EPS:
-6.3
ネットキャッシュフロー:
$-38.56M
1週間 パフォーマンス:
-8.45%
1か月 パフォーマンス:
+44.44%
6か月 パフォーマンス:
-36.59%
1年 パフォーマンス:
-10.65%
1日の値動き範囲:
Value
$2.43
$2.85
1週間の範囲:
Value
$2.245
$6.60
52週間の値動き範囲:
Value
$1.00
$6.60

Sab Biotherapeutics Inc Stock (SABS) Company Profile

Name
名前
Sab Biotherapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
305-845-2813
Name
住所
777 W 41ST ST, MIAMI BEACH
Name
職員
63
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
SABS's Discussions on Twitter

SABS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SABS
Sab Biotherapeutics Inc
2.60 23.13M 0 -45.57M -38.56M -6.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-14 再開されました H.C. Wainwright Buy
2024-10-09 開始されました Craig Hallum Buy
2024-08-28 開始されました Oppenheimer Outperform
2021-11-05 開始されました Chardan Capital Markets Buy

Sab Biotherapeutics Inc (SABS) 最新ニュース

pulisher
02:28 AM

Is SAB Biotherapeutics Inc. a good long term investmentUnmatched profit growth - PrintWeekIndia

02:28 AM
pulisher
12:02 PM

How SAB Biotherapeutics Inc. stock reacts to Fed policy changesExceptional market positioning - jammulinksnews.com

12:02 PM
pulisher
Jul 24, 2025

What analysts say about SAB Biotherapeutics Inc. stockFree Investment Portfolio Suggestions - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

How SAB Biotherapeutics Inc. Equity Warrant stock reacts to Fed policy changesMarket-beating performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement - MSN

Jul 24, 2025
pulisher
Jul 23, 2025

Is SAB Biotherapeutics Inc. Equity Warrant a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

SAB Biotherapeutics Inc. Stock Analysis and ForecastExplosive returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

SAB Biotherapeutics Plunges 10.34% on Private Placement Concerns - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SAB Biotherapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives SAB Biotherapeutics Inc. Equity Warrant stock priceBreakthrough profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about SAB Biotherapeutics Inc. Equity Warrant stockExceptional financial outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

SAB Biotherapeutics Inc. Equity Warrant Stock Analysis and ForecastExplosive trading growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

SAB Biotherapeutics stock price target lowered to $9 by H.C. Wainwright - Investing.com Canada

Jul 22, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Stock Surges 5.06% to Rank 277th in Trading Volume - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock price target raised to $14 from $12 at Oppenheimer - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Inc (SABS) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Soars 24.5% on Volatile Intraday Surge—What’s Fueling the Biotech Rally? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics (SABS) up more than 100% since Jun 30 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Surges 42%—Volatile Rally Reaches 52-Week High Amid Market Turbulence - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Sab Biotherapeutics shares rise 144.48% intraday after raising $175 million in private placement. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Stock Surge: Should You Buy?​ - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock soars after securing $175 million private placement By Investing.com - Investing.com Nigeria

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics stock soars after securing $175 million private placement - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Stock Explodes 54% on Game-Changing $175 Million Private Placement Deal - RagingBull

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics Secures $175M in Private Placement - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

SAB Biotherapeutics announces oversubscribed $175M private placement - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Announces Oversubscribed $175 Million Private Placement - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

SAB BIO Secures $175M Funding Led by Sanofi to Advance Revolutionary Type 1 Diabetes Treatment Through 2028 - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

SABS Stock on the Rise: What’s Next? - timothysykes.com

Jul 21, 2025
pulisher
Jul 20, 2025

Published on: 2025-07-20 20:52:24 - jammulinksnews.com

Jul 20, 2025

Sab Biotherapeutics Inc (SABS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):